HTTP Information: |
---|
X-Cache: HIT
HTTP/1.1 200 OK
Server: Apache
Age: 11808
ETag: "1501509660"
Last-Modified: Mon, 31 Jul 2017 14:01:00 +0000
Connection: close
X-Frame-Options: SAMEORIGIN
Via: 1.1 varnish
Vary: Cookie,Accept-Encoding
Cache-Control: public, max-age=604800
Date: Mon, 31 Jul 2017 17:17:49 GMT
X-UA-Compatible: IE=edge
Content-Type: text/html; charset=utf-8
Expires: Sun, 11 Mar 1984 12:00:00 GMT
X-Varnish: 437879154 437603835
|
Other profiles | |
---|---|
Google Analytics ID: | 23746697-21 |
Known AddThis user account: | Information does not apply |
Google Adsense Publisher: | Information does not apply |
Google+ Identity: | Information does not apply |
Whois details | |
---|---|
Website Address renewal date: | 17/2/7 |
Domain Address Reg. date: | 17/2/7 |
Website address in use until: | 18/2/7 |
Unedited Whois Data: | |
Domain Name: MRKNEWSROOM.COM Registry Domain ID: 2095948720_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2017-02-07T04:21:51Z Creation Date: 2017-02-07T04:21:50Z Registry Expiry Date: 2018-02-07T04:21:50Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: No email disclosed Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: CBRU.BR.NS.ELS-GMS.ATT.NET Name Server: CMTU.MT.NS.ELS-GMS.ATT.NET Name Server: NS6.CUSTOMER.LEVEL3.NET Name Server: NS9.CUSTOMER.LEVEL3.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2017-07-25T19:18:24Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars. | |
Contact phone number: |
DNS information | ||
---|---|---|
US; United States; CO; Colorado; Broomfield; 80021; America/Denver; 39.89380000; -105.11440000; 751 | ns6.customer.level3.net | 209.244.4.85 |
US; United States; 37.75100000; -97.82200000 | cbru.br.ns.els-gms.att.net | 68.94.156.132 |
US; United States; GA; Georgia; America/New_York; 33.74900000; -84.38800000 | ns9.customer.level3.net | 209.244.4.148 |
US; United States; CA; California; San Diego; 92101; America/Los_Angeles; 32.71910000; -117.16070000; 825 | cmtu.mt.ns.els-gms.att.net | 99.99.99.132 |
What others say |
---|
Safety overview | |
---|---|
WOT Child Safety Rank: | Data unavailable |
WOT Safety Rank: | Data unavailable |
Google Safe assessment: | Data unavailable |
Relation to all content | Main tag words | Times search keyword used |
---|---|---|
Data unavailable | Merck Consumer Care | Data unavailable |
Data unavailable | Merck Prescription medicine | Data unavailable |
Data unavailable | Merck Social Media | Data unavailable |
Data unavailable | Merck Media Contacts | Data unavailable |
Data unavailable | Primaxin | Data unavailable |
Data unavailable | Remeron | Data unavailable |
Data unavailable | Crixivan/Stocrin | Data unavailable |
Data unavailable | Proventil | Data unavailable |
Data unavailable | PegIntron | Data unavailable |
Data unavailable | Arcoxia | Data unavailable |
Data unavailable | Intron A | Data unavailable |
Data unavailable | Merck Research | Data unavailable |
Data unavailable | Noxafil | Data unavailable |
Data unavailable | Propecia | Data unavailable |
Data unavailable | Merck Pipeline | Data unavailable |
Data unavailable | Victrelis | Data unavailable |
Data unavailable | Zocor | Data unavailable |
Data unavailable | Invanz | Data unavailable |
Data unavailable | Nasonex | Data unavailable |
Data unavailable | Emend | Data unavailable |
Data unavailable | Vytorin | Data unavailable |
Data unavailable | Merck Newsroom | Data unavailable |
Data unavailable | Merck Earnings | Data unavailable |
Data unavailable | Merck Press Release | Data unavailable |
Data unavailable | Cosopt/Trusopt | Data unavailable |
Data unavailable | Isentress | Data unavailable |
Data unavailable | Remicade | Data unavailable |
Data unavailable | NYSE: MRK | Data unavailable |
Data unavailable | Merck Corporate Responsibility | Data unavailable |
Data unavailable | Temodar | Data unavailable |
Data unavailable | Singulair | Data unavailable |
Data unavailable | Merck Vaccines | Data unavailable |
Data unavailable | Asmanex | Data unavailable |
Data unavailable | Avelox | Data unavailable |
Data unavailable | juvisync | Data unavailable |
Data unavailable | Zetia | Data unavailable |
Data unavailable | Cozaar/Hyzaar | Data unavailable |
Data unavailable | Merck Investor Relations | Data unavailable |
Data unavailable | Janumet | Data unavailable |
Data unavailable | Claritin Rx | Data unavailable |
Data unavailable | Merck Foundation | Data unavailable |
Data unavailable | Merck For Mothers | Data unavailable |
Data unavailable | Integrilin | Data unavailable |
Data unavailable | Merck Animal Health | Data unavailable |
Data unavailable | Proscar | Data unavailable |
Data unavailable | Maxalt | Data unavailable |
Data unavailable | Merck Events | Data unavailable |
Data unavailable | Januvia | Data unavailable |
Data unavailable | zioptan | Data unavailable |
Data unavailable | Clarinex | Data unavailable |
Data unavailable | Cancidas | Data unavailable |
Data unavailable | Simponi | Data unavailable |
Data unavailable | Implanon | Data unavailable |
Data unavailable | Coppertone | Data unavailable |
Data unavailable | Tredaptive | Data unavailable |
Data unavailable | Dulera | Data unavailable |
Data unavailable | Merck Patience assistance program | Data unavailable |
Data unavailable | M-M-R II | Data unavailable |
Data unavailable | Pneumovax | Data unavailable |
Data unavailable | Follistim AQ | Data unavailable |
Data unavailable | NuvaRing | Data unavailable |
Data unavailable | Claritin OTC | Data unavailable |
Data unavailable | V503 | Data unavailable |
Data unavailable | Kenneth C. Frazier | Data unavailable |
Data unavailable | Merck Careers/Jobs | Data unavailable |
Data unavailable | Peter N. Kellogg | Data unavailable |
Data unavailable | RotaTeq | Data unavailable |
Data unavailable | Odanacateb | Data unavailable |
Data unavailable | Peter S. Kim | Data unavailable |
Data unavailable | Gardasil | Data unavailable |
Data unavailable | Adam Schechter | Data unavailable |
Data unavailable | Varivax | Data unavailable |
Data unavailable | Suvorexant | Data unavailable |
Data unavailable | Dr. Scholls | Data unavailable |
Data unavailable | Julie Gerberding | Data unavailable |
Data unavailable | ProQuad | Data unavailable |
Data unavailable | Merck Annual Report | Data unavailable |
Data unavailable | Cerazette | Data unavailable |
Data unavailable | Fosamax | Data unavailable |
Data unavailable | Michael Rosenblatt | Data unavailable |
Data unavailable | Bridion | Data unavailable |
Data unavailable | Zostavax | Data unavailable |
Alexa ranking information | |
---|---|
Past year global rank trend | |
Last Alexa data update: | 18/6/17 |
Ranking delta: | -197 779 |
Country ranking: | Data unavailable |
Links | |
Information does not apply | |
One month trend average stats | |
Global/International rating: | 407 538 |
Target Country: | Data unavailable |
Position based on reach: | Data unavailable |